Fostamatinib Tablets Market: Advancing Targeted Treatment for Immune-Mediated Blood Disorders
Immune-mediated blood disorders can affect the body's ability to maintain healthy blood cell levels and may require specialized treatment approaches. Fostamatinib is an oral medication that works by inhibiting spleen tyrosine kinase (SYK), a protein involved in immune cell signaling. It is approved in certain markets for treating adults with chronic immune thrombocytopenia (ITP) who have had an...
0 Commentarii 0 Distribuiri 2 Views 0 previzualizare